CUDC-101

CAS No. 1012054-59-9

CUDC-101 ( CUDC101;CUDC 101 )

Catalog No. M10074 CAS No. 1012054-59-9

A potent, multi-targeted HDAC, EGFR and HER2 inhibitor with IC50 of 4.4, 2.4, and 15.7 nM, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 39 In Stock
10MG 69 In Stock
25MG 113 In Stock
50MG 186 In Stock
100MG 332 In Stock
500MG 797 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CUDC-101
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, multi-targeted HDAC, EGFR and HER2 inhibitor with IC50 of 4.4, 2.4, and 15.7 nM, respectively.
  • Description
    A potent, multi-targeted HDAC, EGFR and HER2 inhibitor with IC50 of 4.4, 2.4, and 15.7 nM, respectively; Exhibits efficient antiproliferative activity with greater potency (IC50<1 uM) than Vorinostat (SAHA), Erlotinib, Lapatinib; Promotes tumor regression or inhibition in various cancer xenograft models including NSCLC, liver, breast, head and neck, colon, and pancreatic cancers. Solid TumorsPhase 1 Discontinued
  • Synonyms
    CUDC101;CUDC 101
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    EGFR;HDAC;HDAC1;HDAC10;HDAC2;HDAC3;HDAC4;HDAC5;HDAC6;HDAC7;HDAC8;HDAC9;HER2
  • Research Area
    Cancer
  • Indication
    Solid Tumors

Chemical Information

  • CAS Number
    1012054-59-9
  • Formula Weight
    434.49
  • Molecular Formula
    C24H26N4O4
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C(NO)CCCCCCOC1=CC2=C(NC3=CC=CC(C#C)=C3)N=CN=C2C=C1OC
  • Chemical Name
    Heptanamide, 7-[[4-[(3-ethynylphenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-N-hydroxy-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Cai X, et al. J Med Chem. 2010 Mar 11;53(5):2000-9.
2. Lai CJ, et al. Cancer Res. 2010 May 1;70(9):3647-56.
3. Wang J, et al. Mol Cancer Ther. 2013 Jun;12(6):925-36.
molnova catalog
related products
  • SIS17

    SIS17 is a potent and selective HDAC 11 inhibitor with an IC50 value of 0.83 μM. SIS17 is active in cells and inhibited the demyristoylation of a known HDAC11 substrate serine hydroxymethyl transferase 2 without inhibiting other HDACs.

  • Class I and IIB HDAC...

    Class I and IIB HDAC inhibitor 42 is a novel potent, selective class I and IIB inhibitor.

  • Valproic acid

    A HDAC inhibitor that selectively inhibits the catalytic activity of class I HDACs, and induces proteasomal degradation of HDAC2.